<DOC>
	<DOCNO>NCT02942615</DOCNO>
	<brief_summary>Under modern precise radiotherapy technology , clear best dose volume limit index limit value primary level prevention heart injury ; clear best follow-up interval measure heart function breast cancer patient , achieve secondary prevention cardiac injury ; explore combine cardiovascular specialist optimal treatment strategy heart injury treatment breast cancer , tertiary prevention cardiac injury ; put forward rationalization proposal prevention , treatment follow-up breast cancer associate heart injury .</brief_summary>
	<brief_title>The Safety Management Cardiac Toxicity Breast Cancer Patients Under Multidiscipline Therapy .</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Cardiotoxicity</mesh_term>
	<criteria>Patients willing participate research sign inform consent file ; Patients aged 1880 year ; KPS≥70 ; Pathological diagnosis invasive breast cancer ; Patients receive anthracycline/paclitaxel base chemotherapy , herceptin base targeted therapy ; No functional heart disease ; LVEF≥50 % ; Patients receive breast conserving surgery ; Patients receive modified radical mastectomy : T12 N13 T34 N ; Tumor margin negative ; No metastases ; No malignant tumor history . Patients metastases ; Tumor margin positive ; Patients receive modified radical mastectomy T12 N0 ; Patients malignant tumor ; Patients history heart disease ; Patients receive chest radiotherapy previously ; Patients severe organic functional disease ; Unqualified patient sufficient reason ; Can willing sign informed consent file ; Patients autoimmune disease ; Women pregnancy , plan pregnancy lactating .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>